These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 15606513)
1. Antinucleosome antibody is a major autoantibody in localized scleroderma. Sato S; Kodera M; Hasegawa M; Fujimoto M; Takehara K Br J Dermatol; 2004 Dec; 151(6):1182-8. PubMed ID: 15606513 [TBL] [Abstract][Full Text] [Related]
2. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702 [TBL] [Abstract][Full Text] [Related]
3. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus]. Amoura Z; Piette JC Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656 [TBL] [Abstract][Full Text] [Related]
4. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891 [TBL] [Abstract][Full Text] [Related]
5. Antinucleosome antibodies and systemic lupus erythematosus. Düzgün N; Sahin M; Genç Y; Tutkak H Ann N Y Acad Sci; 2007 Aug; 1109():421-8. PubMed ID: 17785331 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases. Půtová I; Dostal C; Becvar R Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus. Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma. Tomimura S; Ogawa F; Iwata Y; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S J Dermatol Sci; 2008 Oct; 52(1):47-54. PubMed ID: 18565735 [TBL] [Abstract][Full Text] [Related]
9. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Chabre H; Amoura Z; Piette JC; Godeau P; Bach JF; Koutouzov S Arthritis Rheum; 1995 Oct; 38(10):1485-91. PubMed ID: 7575698 [TBL] [Abstract][Full Text] [Related]
10. Antigen specificity of antihistone antibodies in localized scleroderma. Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K Arch Dermatol; 1994 Oct; 130(10):1273-7. PubMed ID: 7524451 [TBL] [Abstract][Full Text] [Related]
11. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? Andreoli L; Pregnolato F; Burlingame RW; Allegri F; Rizzini S; Fanelli V; Radice A; Corace C; Sinico RA; Meroni PL; Tincani A J Autoimmun; 2008; 30(1-2):51-7. PubMed ID: 18191541 [TBL] [Abstract][Full Text] [Related]
12. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma. Hayakawa I; Hasegawa M; Takehara K; Sato S Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620 [TBL] [Abstract][Full Text] [Related]
13. [Autoantibodies in systemic lupus erythematosus: spectrum and clinical associations]. Haddouk S; Ben Ayed M; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H Pathol Biol (Paris); 2005 Jul; 53(6):311-7. PubMed ID: 16004941 [TBL] [Abstract][Full Text] [Related]
14. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7. Williams RC; Malone CC; Meyers C; Decker P; Muller S J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548 [TBL] [Abstract][Full Text] [Related]
16. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Mok CC; Ho LY; Leung HW; Wong LG Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493 [TBL] [Abstract][Full Text] [Related]
17. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis. Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012 [TBL] [Abstract][Full Text] [Related]
18. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Amoura Z; Piette JC; Chabre H; Cacoub P; Papo T; Wechsler B; Bach JF; Koutouzov S Arthritis Rheum; 1997 Dec; 40(12):2217-25. PubMed ID: 9416860 [TBL] [Abstract][Full Text] [Related]
19. The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays. Villalta D; Tozzoli R; Bizzaro N; Tonutti E; Ghirardello A; Doria A Ann N Y Acad Sci; 2005 Jun; 1050():176-84. PubMed ID: 16014532 [TBL] [Abstract][Full Text] [Related]
20. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Grootscholten C; van Bruggen MC; van der Pijl JW; de Jong EM; Ligtenberg G; Derksen RH; Berden JH; Arthritis Rheum; 2003 May; 48(5):1355-62. PubMed ID: 12746908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]